Identification of six hub genes and two key pathways in two rat renal fibrosis models based on bioinformatics and

Yueqin Cai1,2, Jingan Chen3, Jingyan Liu4

  • 1School of Basic Medical Sciences, Zhejiang Chinese Medical University, Hangzhou, China.

Insights

This study identifies key pathways and targets in renal fibrosis (RF) using rat models. It highlights potential herbal drug candidates like curcumin for treating this common kidney disease.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Pharmacology

Background:

  • Renal fibrosis (RF) is a major cause of chronic kidney disease mortality.
  • The molecular mechanisms driving RF are not fully understood, necessitating identification of key targets and pathways.
  • Current treatment strategies for RF are limited, underscoring the need for novel therapeutic approaches.

Purpose of the Study:

  • To elucidate the molecular mechanisms of renal fibrosis (RF).
  • To identify key RF-related pathways and hub targets.
  • To predict potential therapeutic drug candidates for RF.

Main Methods:

  • Established adenine and UUO-induced rat models of renal fibrosis.
  • Utilized RNA-Seq for differential gene expression analysis.
  • Employed bioinformatics, including PPI networks and co-expression analysis, for target and pathway screening.
  • Verified findings using qRT-PCR and predicted drug candidates via network pharmacology and molecular docking.

Main Results:

  • Adenine and UUO models showed severe renal structural damage, collagen deposition, and altered biomarker expression (TGF-β1, α-SMA, E-cadherin).
  • Identified 1189 and 1253 differentially expressed genes in the respective models.
  • Discovered two key pathways, AGE-RAGE and NOD-like receptor, with hub targets including Tgfb1, Col1a1, Nlrc4, Casp4, Trpm2, and Il18.
  • Predicted herbal compounds like curcumin, resveratrol, and honokiol as potential drug candidates with strong target binding affinities.

Conclusions:

  • Identified AGE-RAGE and NOD-like receptor pathways as critical in renal fibrosis.
  • Highlighted hub targets involved in inflammation, ECM formation, myofibroblast generation, and pyroptosis.
  • Provided potential therapeutic strategies and drug candidates for RF management.

Related Concept Videos